Bioprocessing Recombinant Proteins

Infectious diseases and cancers are among the main causes of human deaths worldwide. One successful avenue found to treat these diseases is the large-scale production of therapeutic proteins. As a result, the demand for protein expression hosts and accompanying advanced bioprocessing technologies has increased. Read about a workflow for efficient purification of a low-expressing recombinant protein using mixed-mode resins.
ChromatographyPast WebinarsWebinars

Integrating Viral Clearance into Your Process Development — A Case Study Using a Mixed‑Mode Chromatography Resin

Presented by: Akunna Iheanacho, Director of Research and Development at Texcell – North America
Xuemei He, R&D Manager, Chromatograpy Media Chemistry at Bio-Rad Laboratories

View on demand

Learn about evaluating viral clearance using a DOE approach with a mixed-mode chromatography resin.

Nuvia aPrime Banner Bioradiations Bio-Rad
ArticlesChromatographyFeatured StoriesTechnical Reports

Purification of Antibodies with Nuvia aPrime 4A Hydrophobic Anion Exchange Resin

Our new hydrophobic anion exchange mixed-mode resin, Nuvia aPrime 4A, has been developed to overcome existing challenges in antibody purification. See how we purified an acidic and basic antibody through bind-elute and flow-through modes of purification, respectively, and helped to improve process productivity and economy.
Stop Compromising between High Yield and High Purity in Downstream Purifications
ArticlesChromatographyFeatured Stories

Stop Compromising between High Yield and High Purity in Downstream Purifications

When it comes to downstream protein purifications, does it feel like you’re in a constant tug of war between high yield and high purity? With Bio-Rad’s Nuvia aPrime 4A Resin, you don’t have to choose. With both ion exchange and mixed-mode properties, see how the resin is able to deliver simultaneous purity and yield, for even difficult-to-purify proteins.